Selection of Resistance in Protease Inhibitor-Experienced, Human Immunodeficiency Virus Type 1-Infected Subjects Failing Lopinavir- and Ritonavir-Based Therapy: Mutation Patterns and Baseline Correlates

Ítems similars

• Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients
  per: King, Martin S., et al.
  Publicat: (2007)
• In Vitro Antiviral Interaction of Lopinavir with Other Protease Inhibitors
  per: Molla, Akhteruzzaman, et al.
  Publicat: (2002)
• Identification of Genotypic Changes in Human Immunodeficiency Virus Protease That Correlate with Reduced Susceptibility to the Protease Inhibitor Lopinavir among Viral Isolates from Protease Inhibitor-Experienced Patients
  per: Kempf, Dale J., et al.
  Publicat: (2001)
• Virological and Pharmacological Parameters Predicting the Response to Lopinavir-Ritonavir in Heavily Protease Inhibitor-Experienced Patients
  per: Marcelin, Anne-Geneviève, et al.
  Publicat: (2005)
• Estimation of Serum-Free 50-Percent Inhibitory Concentrations for Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir
  per: Hickman, Dean, et al.
  Publicat: (2004)